Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year gross profit growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P36
Within normal range
Average
10.75%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 100.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 100.00% |
| Q1 2022 | -99.54% |
| Q4 2021 | 30.92% |
| Q3 2021 | 21.15% |
| Q2 2021 | 45.19% |
| Q1 2021 | -15.83% |
| Q4 2020 | 16.23% |
| Q3 2020 | -740.80% |
| Q2 2020 | 0.00% |
| Q1 2020 | -100.00% |
| Q4 2019 | -42.70% |
| Q3 2019 | 267.42% |
| Q2 2019 | -56.69% |
| Q1 2019 | 68.52% |
| Q4 2018 | -44.38% |
| Q3 2018 | -21.09% |
| Q2 2018 | 87.42% |
| Q1 2018 | 148.37% |
| Q4 2017 | -78.56% |
| Q3 2017 | -11.65% |
| Q2 2017 | -29.68% |
| Q1 2017 | 741.97% |
| Q4 2016 | -74.65% |
| Q3 2016 | -11.15% |
| Q2 2016 | -19.61% |
| Q1 2016 | 48.87% |
| Q4 2015 | 0.40% |